N-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases
- 21 February 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (5) , 3913-3922
Abstract
Drug-resistant pathogens pose a global challenge to public health as they cause diseases that are extremely difficult to cure. Metallo-β-lactamases (MBLs) are a diverse set of zinc-containing enzymes that catalyze the hydrolysis of β-lactam drugs, including carbapenems, which are considered as the last resort to fight severe infections. To restore the activity of current β-lactam antibiotics and to offer an orthogonal strategy to the discovery of new antibiotics, we have identified a series of polar N-aryl mercaptopropionamide derivatives as potent inhibitors of several class B1 MBLs. We have identified a hit structure with high selectivity restoring the effect of imipenem and reducing minimum inhibitory concentration (MIC) values up to 256-fold in resistant isolates from Escherichia coli. Furthermore, the combination of imipenem with our inhibitor showed in vivo efficacy in a Galleria mellonella model, increasing the survival rate of infected larvae by up to 31%.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (PR1405/7-1)
- Alexander von Humboldt-Stiftung
- Helmholtz Association
- H2020 European Research Council (757913)
This publication has 53 references indexed in Scilit:
- Evaluation of 14 Organic Solvents and Carriers for Screening Applications in Zebrafish Embryos and LarvaePLOS ONE, 2012
- Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processesMolecular Aspects of Medicine, 2012
- Fluorogenic cephalosporin substrates for β-lactamase TEM-1Analytical Biochemistry, 2011
- Structure of New Delhi metallo-β-lactamase 1 (NDM-1)Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2011
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamilyBiochemical Pharmacology, 2007
- Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammationJournal of Leukocyte Biology, 2007
- RNAse A‐like enzymes in serum inhibit the anti‐neoplastic activity of siRNA targeting polo‐like kinase 1International Journal of Cancer, 2007
- Thiomandelic Acid, a Broad Spectrum Inhibitor of Zinc β-LactamasesJournal of Biological Chemistry, 2001
- The structure of β-lactamasesPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980